NCT03091192 2026-01-23Savolitinib vs. Sunitinib in MET-driven PRCC.AstraZenecaPhase 3 Active not recruiting60 enrolled 15 charts
NCT06111235 2026-01-12A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBTCG Oncology, Inc.Phase 3 Active not recruiting367 enrolled